Followers | 28 |
Posts | 1197 |
Boards Moderated | 0 |
Alias Born | 05/14/2014 |
Monday, March 06, 2017 4:12:11 PM
So, in short, a patient with no previous reliance on cannabis starts using it, starts suffering from nausea, continues using it for 8 months while enduring the additional symptoms, ceases using the cannabis in October, and 1 month later the nausea symptoms improved.
That sure doesn't sound like they have any case or proof whatsoever for demonstrating that pesticide contamination specifically caused those symptoms of nausea and vomiting. It could have, quite simply, been a sensitivity to something else associated with the cannabis. Prolonged exposure to nearly any substance could draw out nausea (and more) to someone that just happens to have the wrong mix of certain sensitivities and other conditions.
I could easily find someone to give testimony that smoking or consuming MJ products made them very nauseous, so I'm sure Organigram could do the same or have a medical professional set the record straight.
But the plaintiff can cry "negligence" into the night and walk away with a few bucks. Organigram already has enough bad press lately, and no one wants to waste time and money on a long court battle. So, it's a play for quick and easy money. Expect a settlement in a short timeframe.
JMHO and disclaimer: I am not a legal advisor or registered attorney. Do not take my above comments as legal advice.
Recent OGI News
- Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend] • Edgar (US Regulatory) • 09/03/2024 01:30:26 PM
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 09/03/2024 01:29:42 PM
- Organigram Closes Second Tranche of Previously Announced BAT Private Placement Investment • Business Wire • 09/03/2024 10:00:00 AM
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 08/13/2024 11:25:59 AM
- Organigram Reports Third Quarter Fiscal 2024 Results • Business Wire • 08/13/2024 10:30:00 AM
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 08/07/2024 03:19:22 PM
- Organigram Product Development Collaboration Completes Landmark Clinical Study on Nanoemulsion Technology • Business Wire • 08/07/2024 10:00:00 AM
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 08/06/2024 02:32:27 PM
- Organigram to Report Third Quarter Fiscal 2024 Results on August 13, 2024 • Business Wire • 08/06/2024 10:00:00 AM
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 07/29/2024 03:20:28 PM
- Organigram Announces Appointment of Craig Harris to Board of Directors • Business Wire • 07/29/2024 10:00:00 AM
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 07/24/2024 09:06:57 PM
- Organigram to Bolster Auto-Flower and Rare Cannabinoid Portfolio with Partial Third Tranche Investment of US $1M into Phylos • Business Wire • 07/24/2024 10:00:00 AM
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 07/12/2024 07:13:48 PM
- Organigram investe in Sanity Group, società leader tedesca nel settore della cannabis • Business Wire • 06/26/2024 01:15:00 PM
- Organigram investiert in Sanity Group, ein führendes deutsches Cannabisunternehmen • Business Wire • 06/26/2024 01:15:00 PM
- Organigram investit dans Sanity Group, un chef de file du cannabis en Allemagne • Business Wire • 06/26/2024 01:15:00 PM
- Organigram Invests in Sanity Group, a Leading German Cannabis Company • Business Wire • 06/25/2024 12:00:00 PM
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 05/28/2024 01:38:30 PM
- Organigram Signs Three Year Supply Agreement with Avida Medical in UK • Business Wire • 05/28/2024 10:00:00 AM
- US Futures Remain Steady Amid Wall Street Caution Ahead of April PPI Report • IH Market News • 05/14/2024 11:18:01 AM
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 05/14/2024 11:17:16 AM
- Organigram Reports Second Quarter Fiscal 2024 Results • Business Wire • 05/14/2024 10:00:00 AM
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 05/08/2024 03:29:51 PM
- Organigram to Report Second Quarter Fiscal 2024 Results on May 14, 2024 • Business Wire • 05/08/2024 12:00:00 PM
North Bay Resources Announces Assays up to 5 oz/ton Gold, 1.5 oz/ton Platinum, 0.5 oz/ton Palladium, and 0.5 oz/ton Rhodium at Mt. Vernon Gold Mine, Sierra County, California • NBRI • Oct 4, 2024 9:15 AM
Basanite, Inc. Appoints Ali Manav as Interim Chief Executive Officer • BASA • Oct 3, 2024 9:15 AM
Integrated Ventures Announces Launch of MedWell Facilities, LLC and Lease Agreement with Giant Fitness Clubs • INTV • Oct 3, 2024 8:45 AM
Beyond the Horizon: Innovative Drug Combinations Offer New Hope for Alzheimer's and More • NVS • Oct 3, 2024 8:45 AM
SMX and FinGo Enter Into Collaboration Mandate to Develop a Joint 'Physical to Digital' Platform Service To Enhance Natural Rubber Industry's Ability to Report on Sustainable and Ethical Supply Chains • SMX • Oct 3, 2024 7:00 AM
Transforming Alzheimer's Treatment: Innovative Combinations to Boost Cognition • PFE • Oct 2, 2024 9:00 AM